Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor

Zhuo Wang, Daniel J. Stuckey, Colin E. Murdoch, Patrizia Camelliti, Gregory Y.H. Lip, Martin Griffin

Research output: Contribution to journalArticle